May is Ocular Melanoma Awareness Month
Ocular (uveal) melanoma is a rare but dangerous disease. It involves the iris, ciliary body, and/or choroid, which are collectively referred to as the uvea, and the tumors develop in the pigmented
read more
Texas Retina Participating in New Phase III Clinical Trial for Uveal Melanoma
Under the leadership of principal investigator Timothy Fuller, MD, Texas Retina will soon begin enrolling patients in the OptimUM-10 clinical trial, a randomized, Phase III, open-label study of neoadjuvant darovasertib in subjects with primary non-metastatic
read more